Sign in
4

Changes in Ownership

SUTRO BIOPHARMA, INC. Filed Acc 0001872398-26-000003

Chief Executive Officer gave up 282 shares (to pay taxes)

  • Chief Executive Officer acquired 788 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chung Jane Chief Executive Officer 2026-03-04 Option exercise +788 21,567 D
Chung Jane Chief Executive Officer 2026-03-04 Shares withheld for taxes −282 $21.31 $6,009 21,285 D
Derivatives
Chung Jane Chief Executive Officer 2026-03-04 Option exercise · Restricted Stock Units (RSUs) −788 0 D
Loading xslF345X05/form4-03062026_090306.xml…